Multi-contrast late enhancement CMR determined gray zone and papillary muscle involvement predict appropriate ICD therapy in patients with ischemic heart disease

Journal of Cardiovascular Magnetic Resonance

Volumn 15, Issue 1, 2013, Pages

  Yang, Yuesong ^a   Connelly, Kim A ^b   Zeidan Shwiri, Tawfiq ^a   Lu, Yingli ^a   Paul, Gideon ^a   Roifman, Idan ^a   Zia, Mohammad I ^a   Graham, John J ^b   Dick, Alexander J ^c   Crystal, Eugene ^a   Wright, Graham A ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

Cardiovascular magnetic resonance; Implantable cardioverter defibrillator; Infarct heterogeneity; Ischemic heart disease; Late gadolinium enhancement

Indexed keywords

GADOLINIUM; CONTRAST MEDIUM;

ADULT; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; ELECTRIC SHOCK; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE; HEART PAPILLARY MUSCLE; HEART VENTRICLE ARRHYTHMIA; HUMAN; IMAGE QUALITY; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; IMPLANTATION; ISCHEMIC HEART DISEASE; MALE; PRIORITY JOURNAL; AGED; ARRHYTHMIAS, CARDIAC; CARDIOVERSION; COMPLICATION; DEVICES; DIAGNOSTIC USE; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; MIDDLE AGED; MYOCARDIAL INFARCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PATIENT SELECTION; PREDICTIVE VALUE; PROCEDURES;

AGED; ARRHYTHMIAS, CARDIAC; CONTRAST MEDIA; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PAPILLARY MUSCLES; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 84879426414     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-15-57     Document Type: Article

References (37)

1. Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop. Fishman GI, Chugh SS, Dimarco JP, Albert CM, Anderson ME, Bonow RO, Buxton AE, Chen PS, Estes M, Jouven X, Kwong R, Lathrop DA, Mascette AM, Nerbonne JM, O'Rourke B, Page RL, Roden DM, Rosenbaum DS, Sotoodehnia N, Trayanova NA, Zheng ZJ, Circulation 2010 122 2335 2348 10.1161/CIRCULATIONAHA.110.976092 21147730
2. Implantable Implantable Cardioverter-Defibrillators after Myocardial Infarction. Myerburg RJ, N Engl J Med 2008 359 2245 2253 10.1056/NEJMra0803409 19020326
3. Implantable cardioverter-defibrillators: indications and unresolved issues. Kedia R, Saeed M, Tex Heart Inst J 2012 39 335 341 22719141
4. ACC / AHA / HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: executive summary. Epstein AE, Dimarco JP, Ellenbogen KA, Estes NA III, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO, Heart Rhythm 2008 5 934 955 10.1016/j.hrthm.2008.04.015 18534377
5. Ip JH; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, N Engl J Med 2005 352 225 237 10.1056/NEJMoa043399 15659722 (Pubitemid 40110811)
6. Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year findings from the Oregon Sudden Unexpected Death Study. Stecker EC, Vickers C, Waltz J, Socoteanu C, John BT, Mariani R, McAnulty JH, Gunson K, Jui J, Chugh SS, J Am Coll Cardiol 2006 47 1161 1166 10.1016/j.jacc.2005.11.045 16545646
7. Cardiovascular magnetic resonance in patients with myocardial infarction: current and emerging applications. Kim HW, Farzaneh-Far A, Kim RJ, J Am Coll Cardiol 2009 55 1 16 10.1016/j.jacc.2009.06.059 20117357
8. Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. Bello D, Fieno DS, Kim RJ, Pereles FS, Passman R, Song G, Kadish AH, Goldberger JJ, J Am Coll Cardiol 2005 45 1104 1108 10.1016/j.jacc.2004.12.057 15808771 (Pubitemid 40432446)
9. Imaging myocardial scar and arrhythmic risk prediction - a role for the electrocardiogram ? Strauss DG, Wu KC, J Electrocardiol 2009 42 138 1 8 19004454
10. The extent of left ventricular scar quantified by late gadolinium enhancement MRI is associated with spontaneous ventricular arrhythmias in patients with coronary artery disease and implantable cardioverter- defibrillators. Scott PA, Morgan JM, Carroll N, Murday DC, Roberts PR, Peebles CR, Harden SP, Curzen NP, Circ Arrhythm Electrophysiol 2011 4 324 330 10.1161/CIRCEP.110.959544 21493964
11. Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Nazarian S, Bluemke DA, Lardo AC, Zviman MM, Watkins SP, Dickfeld TL, Meininger GR, Roguin A, Calkins H, Tomaselli GF, Weiss RG, Berger RD, Lima JA, Halperin HR, Circulation 2005 112 2821 2825 10.1161/CIRCULATIONAHA.105.549659 16267255 (Pubitemid 41641676)
12. Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death. Iles L, Pfluger H, Lefkovits L, Butler MJ, Kistler PM, Kaye DM, Taylor AJ, J Am Coll Cardiol 2011 57 821 828 10.1016/j.jacc.2010.06.062 21310318
13. Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Yan AT, Shayne AJ, Brown KA, Gupta SN, Chan CW, Luu TM, Di Carli MF, Reynolds HG, Stevenson WG, Kwong RY, Circulation 2006 114 32 39 10.1161/CIRCULATIONAHA.106.613414 16801462 (Pubitemid 44305272)
14. Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Schmidt A, Azevedo CF, Cheng A, Gupta SN, Bluemke DA, Foo TK, Gerstenblith G, Weiss RG, Marbán E, Tomaselli GF, Lima JA, Wu KC, Circulation 2007 115 2006 2014 10.1161/CIRCULATIONAHA.106.653568 17389270 (Pubitemid 46625951)
15. Quantitative tissue characterization of infarct core and border zone in patients with ischemic cardiomyopathy by magnetic resonance is associated with future cardiovascular events. Heidary S, Patel H, Chung J, Yokota H, Gupta SN, Bennett MV, Katikireddy C, Nguyen P, Pauly JM, Terashima M, McConnell MV, Yang PC, J Am Coll Cardiol 2010 55 2762 2768 10.1016/j.jacc.2010.01.052 20538171
16. Inversion-recovery-prepared SSFP for cardiac-phase-resolved delayed-enhancement MRI. Detsky JS, Stainsby JA, Vijayaraghavan R, Graham JJ, Dick AJ, Wright GA, Magn Reson Med 2007 58 365 372 10.1002/mrm.21291 17654582 (Pubitemid 47267654)
17. Multicontrast late gadolinium enhancement imaging enables viability and wall motion assessment in a single acquisition with reduced scan times. Connelly KA, Detsky JS, Graham JJ, Paul G, Vijayaragavan R, Dick AJ, Wright GA, J Magn Reson Imaging 2009 30 771 777 10.1002/jmri.21907 19787723
18. Papillary muscle involvement in myocardial infarction: initial results using multicontrast late-enhancement MRI. Yang Y, Connelly K, Graham JJ, Detsky J, Lee T, Walcarius R, Paul G, Wright GA, Dick AJ, J Magn Reson Imaging 2011 33 211 216 10.1002/jmri.22394 21182141
19. Reproducible classification of infarct heterogeneity using fuzzy clustering on multicontrast delayed enhancement magnetic resonance images. Detsky JS, Paul G, Dick AJ, Wright GA, IEEE Trans Med Imaging 2009 28 1606 1614 19783498
20. Post-infarction ventricular arrhythmias originating in papillary muscles. Bogun F, Desjardins B, Crawford T, Good E, Jongnarangsin K, Oral H, Chugh A, Pelosi F, Morady F, J Am Coll Cardiol 2008 51 1794 1802 10.1016/j.jacc.2008.01. 046 18452787 (Pubitemid 351608500)
21. Ventricular tachycardia originating from the posterior muscle in the left ventricle: a distinct clinical syndrome. Doppalapudi H, Yamada T, McElderry HT, Plumb VJ, Epstein AE, Kay GN, Circ Arrhythm Electrophysiol 2008 1 23 29 10.1161/CIRCEP.107.742940 19808390
22. Long-term benefit of primary prevention with an implantable cardioverter-defibrillator: an extended 8-year follow-up study of the Multicenter Automatic Defibrillator Implantation Trial II. Goldenberg I, Gillespie J, Moss AJ, Hall WJ, Klein H, McNitt S, Brown MW, Cygankiewicz I, Zareba W, Executive Committee of the Multicenter Automatic Defibrillator Implantation Trial II, Circulation 2010 122 1265 1271 10.1161/CIRCULATIONAHA. 110.940148 20837894
23. The cost effectiveness of implantable cardioverter-defibrillators: results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. Zwanziger J, Hall WJ, Dick AW, Zhao H, Mushlin AI, Hahn RM, Wang H, Andrews ML, Mooney C, Wang H, Moss AJ, J Am Coll Cardiol 2006 47 2310 2318 10.1016/j.jacc.2006.03.032 16750701 (Pubitemid 43795065)
24. Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation. Klem I, Weinsaft JW, Bahnson TD, Hegland D, Kim HW, Hayes B, Parker MA, Judd RM, Kim RJ, J Am Coll Cardiol 2012 60 408 20 10.1016/j.jacc.2012.02.070 22835669
25. Myocardial scar extent evaluated by cardiac magnetic resonance imaging in ICD patients: relationship to spontaneous VT during long-term follow-up. Bernhardt P, Stiller S, Kottmair E, Binner L, Spiess J, Grossmann G, Rasche V, Walcher D, Hombach V, Int J Cardiovasc Imaging 2011 27 893 900 10.1007/s10554-010-9726-9 20957518
26. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator. Roes SD, Borleffs CJ, van der Geest RJ, Westenberg JJ, Marsan NA, Kaandorp TA, Reiber JH, Zeppenfeld K, Lamb HJ, de Roos A, Schalij MJ, Bax JJ, Circ Cardiovasc Imaging 2009 2 183 190 10.1161/CIRCIMAGING.108.826529 19808591
27. Combined cardiac magnetic resonance imaging and C-reactive protein levels identify a cohort at low risk for defibrillator firings and death. Wu KC, Gerstenblith G, Guallar E, Marine JE, Dalal D, Cheng A, Marbán E, Lima JA, Tomaselli GF, Weiss RG, Circ Cardiovasc Imaging 2012 5 178 186 10.1161/CIRCIMAGING.111.968024 22267750
28. Prediction of arrhythmic events in ischemic and dilated cardiomyopathy patients referred for implantable cardiac defibrillator: evaluation of multiple scar quantification measures for late gadolinium enhancement magnetic resonance imaging. Gao P, Yee R, Gula L, Krahn AD, Skanes A, Leong-Sit P, Klein GJ, Stirrat J, Fine N, Pallaveshi L, Wisenberg G, Thompson TR, Prato F, Drangova M, White JA, Circ Cardiovasc Imaging 2012 5 448 456 10.1161/CIRCIMAGING.111.971549 22572740
29. Pursuing the "Holy Grail" Dickfield T, Circ Cardiovasc Imaging 2012 5 167 170 10.1161/CIRCIMAGING.112.972935 22438421
30. Whole mount heart histology: a new gold standard for myocardial damage validation in experimental cardiac MRI studies? Yang Y, Liu K, Wang D, Pop M, Detsky J, Dick AJ, Yaffe MJ, Wright GA, Proc Intl Soc Mag Reson Med 2010 18 3643
31. Comparision of scar morphology by 3D multi-contrast late enhancement MRI, 3D DW-MRI and histology in a pig model of chronic infarct [abstract]. Pop M, Ramanan V, Yang Y, Ghugre N, Qiang B, McVeigh ER, Dick AJ, Wright GA, Proc Intl Soc Mag Reson Med 2010 18 3644
32. Scar size and characteristics assessed by CMR predict ventricular arrhythmias in ischaemic cardiomyopathy: comparison of previously validated models. de Haan S, Meijers TA, Knaapen P, Beek AM, van Rossum AC, Allaart CP, Heart 2011 97 1951 1956 10.1136/heartjnl-2011-300060 21917670
33. Predictors of successful catheter ablation of ventricular arrhythmias arising from the papillary muscles. Yokokawa M, Good E, Desjardins B, Crawford T, Jongnarangsin K, Chugh A, Pelosi F Jr, Oral H, Morady F, Bogun F, Heart Rhythm 2010 7 1654 1659 10.1016/j.hrthm.2010.07.013 20637311
34. Resection of scarred papillary muscles improves outcome after surgery for ventricular tachycardia. Kron IL, DiMarco JP, Nolan SP, Lerman BB, Ann Surg 1986 203 685 689 10.1097/00000658-198606000-00014 3718031
35. Noninvasive identification of ventricular tachycardia-related conducting channels using contrast-enhanced magnetic resonance imaging in patients with chronic myocardial infarction: comparison of signal intensity scar mapping and endocardial voltage mapping. Perez-David E, Arenal A, Rubio-Guivernau JL, del Castillo R, Atea L, Arbelo E, Caballero E, Celorrio V, Datino T, Gonzalez-Torrecilla E, Atienza F, Ledesma-Carbayo MJ, Bermejo J, Medina A, Fernández-Avilés F, J Am Coll Cardiol 2011 57 184 194 10.1016/j.jacc.2010.07.043 21211689
36. Magnetic resonance identification of the ventricular tachycardia critical isthmus: finding the needle in the haystack. Halperin HR, Nazarian S, J Am Coll Cardiol 2011 57 195 197 10.1016/j.jacc.2010.07.042 21211690
37. Papillary muscles do not attach directly to the solid heart wall. Axel L, Circulation 2004 109 3145 3148 10.1161/01.CIR.0000134276.06719.F3 15197146